European Archives - Page 570 of 1472 - European Medical Journal

EMJ Urology 12 [Supplement 2] 2024

Explore the latest insights into the multifaceted aspects of prostate cancer (PCa) treatment presented at the 2024 European Association…

World Mental Health Day with Boehringer Ingelheim’s Nedim Pipic

Nedim Pipic, Senior Vice President and Global Therapeutic Area Head for Mental Health, Boehringer Ingelheim marks World Mental Health Day.

ESC 2024 Interview: Lis Neubeck

EMJ spoke to Lis Neubeck, Professor of Nursing and Head of Cardiovascular Health, Edinburgh Napier University, UK, at the European Society…

ESMO 2024 Interview: Jianjun Zhang

I think oncology has been at the bottom of my heart since I was in high school. When I was a young kid, my dream career was to become an…

US scientists win Nobel Prize for Medicine for discovering microRNA

American researchers Victor Ambros and Gary Ruvkun have been awarded the 2024 Nobel Prize in Physiology or Medicine for their pioneering discovery of microRNA.

Sudden Unexpected Infant Deaths Rose During the COVID-19 Pandemic

A study has revealed an increase in the rates of sudden unexpected infant death and sudden infant death syndrome during the COVID-19 pandemic compared to pre-pandemic levels.

PROMISE Criteria Accurately Predicts Survival in Prostate Cancer

Researchers have validated the prognostic value of PSMA-PET findings using PROMISE criteria to predict overall survival in prostate cancer patients

Ultrafine Particle Exposure Increases Respiratory Infections in Children: ERS 2024

A study shows that brief exposure to ultrafine particles in the air raises the risk of respiratory infections in children.

Modern Radiotherapy Techniques Improve Quality of Life for Patients with Head and Neck Cancer

A study has shown that modern radiotherapy techniques, including volumetric modulated arc therapy, significantly improve quality of life in head and neck cancer patients

Antipsychotic Use Increases Infection Risk During COVID-19

A new study reveals that people with schizophrenia treated with antipsychotics face higher risks of severe respiratory infections, particularly during the COVID-19 pandemic.